Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chen Hu

Showing results (1061-1070 of 1,174) with videos related to

Pageof 118
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 7, 2021
Association of different fractionation schedules for prophylactic cranial irradiation with toxicity and brain metastases-free survival in stage III non-small cell lung cancer: A pooled analysis of individual patient data from three randomized trialsWillem J A Witlox, Bram L T Ramaekers, Benjamin Lacas, et al.
Scientific Reports|March 30, 2017
Irreversible inhibition of BTK kinase by a novel highly selective inhibitor CHMFL-BTK-11 suppresses inflammatory response in rheumatoid arthritis modelHong Wu, Qiong Huang, Ziping Qi, et al.
IEEE Transactions on Biomedical Circuits and Systems|April 4, 2017
Ultrahigh-Density 256-Channel Neural Sensing Microsystem Using TSV-Embedded Neural ProbesYu-Chieh Huang, Po-Tsang Huang, Shang-Lin Wu, et al.
Therapeutic Advances in Medical Oncology|June 18, 2019
Axitinib overcomes multiple imatinib resistant cKIT mutations including the gatekeeper mutation T670I in gastrointestinal stromal tumorsFeiyang Liu, Fengming Zou, Cheng Chen, et al.
European Journal of Medicinal Chemistry|June 20, 2017
Structure-activity relationship investigation for benzonaphthyridinone derivatives as novel potent Bruton's tyrosine kinase (BTK) irreversible inhibitorsBeilei Wang, Yuanxin Deng, Yongfei Chen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 21, 2017
Randomized Phase II Study of Preoperative Chemoradiotherapy ± Panitumumab Followed by Consolidation Chemotherapy in Potentially Operable Locally Advanced (Stage IIIa, N2+) Non-Small Cell Lung Cancer: NRG Oncology RTOG 0839Martin J Edelman, Chen Hu, Quynh-Thu Le, et al.
Science Advances|April 2, 2020
Nanoparticle interactions with immune cells dominate tumor retention and induce T cell-mediated tumor suppression in models of breast cancerPreethi Korangath, James D Barnett, Anirudh Sharma, et al.
International Journal of Radiation Oncology, Biology, Physics|February 8, 2026
Modeling Time-Dependent Recovery to Improve Esophagitis Prediction in Thoracic ReirradiationCecilia F P M de Sousa, Victoria L Doss, Elaina Hales, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|November 14, 2024
Postoperative chemoradiotherapy with capecitabine and oxaliplatin <i>vs.</i> capecitabine for pathological stage N2 rectal cancerNing Li, Yuan Zhu, Luying Liu, et al.
JAMA Psychiatry|October 4, 2023
Individual-Level Risk Prediction of Return to Use During Opioid Use Disorder TreatmentSean X Luo, Daniel J Feaster, Ying Liu, et al.
Pageof 118

Showing results (1061-1070 of 1,174) with videos related to

Sort By:
Pageof 118
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 7, 2021
Association of different fractionation schedules for prophylactic cranial irradiation with toxicity and brain metastases-free survival in stage III non-small cell lung cancer: A pooled analysis of individual patient data from three randomized trialsWillem J A Witlox, Bram L T Ramaekers, Benjamin Lacas, et al.
Scientific Reports|March 30, 2017
Irreversible inhibition of BTK kinase by a novel highly selective inhibitor CHMFL-BTK-11 suppresses inflammatory response in rheumatoid arthritis modelHong Wu, Qiong Huang, Ziping Qi, et al.
IEEE Transactions on Biomedical Circuits and Systems|April 4, 2017
Ultrahigh-Density 256-Channel Neural Sensing Microsystem Using TSV-Embedded Neural ProbesYu-Chieh Huang, Po-Tsang Huang, Shang-Lin Wu, et al.
Therapeutic Advances in Medical Oncology|June 18, 2019
Axitinib overcomes multiple imatinib resistant cKIT mutations including the gatekeeper mutation T670I in gastrointestinal stromal tumorsFeiyang Liu, Fengming Zou, Cheng Chen, et al.
European Journal of Medicinal Chemistry|June 20, 2017
Structure-activity relationship investigation for benzonaphthyridinone derivatives as novel potent Bruton's tyrosine kinase (BTK) irreversible inhibitorsBeilei Wang, Yuanxin Deng, Yongfei Chen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 21, 2017
Randomized Phase II Study of Preoperative Chemoradiotherapy ± Panitumumab Followed by Consolidation Chemotherapy in Potentially Operable Locally Advanced (Stage IIIa, N2+) Non-Small Cell Lung Cancer: NRG Oncology RTOG 0839Martin J Edelman, Chen Hu, Quynh-Thu Le, et al.
Science Advances|April 2, 2020
Nanoparticle interactions with immune cells dominate tumor retention and induce T cell-mediated tumor suppression in models of breast cancerPreethi Korangath, James D Barnett, Anirudh Sharma, et al.
International Journal of Radiation Oncology, Biology, Physics|February 8, 2026
Modeling Time-Dependent Recovery to Improve Esophagitis Prediction in Thoracic ReirradiationCecilia F P M de Sousa, Victoria L Doss, Elaina Hales, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|November 14, 2024
Postoperative chemoradiotherapy with capecitabine and oxaliplatin <i>vs.</i> capecitabine for pathological stage N2 rectal cancerNing Li, Yuan Zhu, Luying Liu, et al.
JAMA Psychiatry|October 4, 2023
Individual-Level Risk Prediction of Return to Use During Opioid Use Disorder TreatmentSean X Luo, Daniel J Feaster, Ying Liu, et al.
Pageof 118